This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Costa A, Daidone MG, Daprai L, Villa R, Cantu S, Pilotti S et al. (2006). Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. Cancer Res 66: 8918–8924.
Johnson JE, Gettings EJ, Schwalm J, Pei J, Testa JR, Litwin S et al. (2007). Whole-genome profiling in liposarcomas reveals genetic alterations common to specific telomere maintenance mechanisms. Cancer Res 67: 9221–9228.
Johnson JE, Varkonyi RJ, Schwalm J, Cragle R, Klein-Szanto A, Patchefsky A et al. (2005). Multiple mechanisms of telomere maintenance exist in liposarcomas. Clin Cancer Res 11: 5347–5355.
Lafferty-Whyte K, Bilsland AE, Hoare SF, Burns S, Zaffaroni N, Cairney CJ et al. (2010). TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expression. Neoplasia 12: 405–414.
Lafferty-Whyte K, Cairney CJ, Will MB, Serakinci N, Daidone MG, Zaffaroni N et al. (2009). A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT. Oncogene 28: 3765–3774.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Keith, W., Lafferty-Whyte, K., Cairney, C. et al. Response to ‘Validating a gene expression signature proposed to differentiate liposarcomas that use different telomere maintenance mechanisms’. Oncogene 31, 267–268 (2012). https://doi.org/10.1038/onc.2011.374
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.374